Implementing digital mental health interventions at scale: one-year evaluation of a national digital CBT service in Ireland.
Anxiety
Cognitive behavioral therapy
Depression
Digital
National Health Service
Journal
International journal of mental health systems
ISSN: 1752-4458
Titre abrégé: Int J Ment Health Syst
Pays: England
ID NLM: 101294224
Informations de publication
Date de publication:
10 Oct 2023
10 Oct 2023
Historique:
received:
13
10
2022
accepted:
31
07
2023
medline:
11
10
2023
pubmed:
11
10
2023
entrez:
11
10
2023
Statut:
epublish
Résumé
In recent years, exponential growth in digital innovations and internet access has provided opportunities to deliver health services at a much greater scale than previously possible. Evidence-based technology-enabled interventions can provide cost-effective, accessible, and resource-efficient solutions for addressing mental health issues. This study evaluated the first year of a supported digital cognitive behavioral therapy (CBT) service provided by the national health service in Ireland, which has been accessible to individuals who receive a referral from one of five referring groups: General Practitioners, Primary Care Psychology, Counselling Primary Care, Community Mental Health, and Jigsaw (a nationwide youth mental health service). A retrospective, observational study examining data from the service between April 2021 to April 2022 was conducted. Descriptive statistics on referrals, account activations, user demographics, program usage, and user satisfaction were extracted, and pre-to-post clinical outcomes for depression measured by the Patient Health Questionnaire-9 and for anxiety measured by the Generalised Anxiety Disorder-7 were analysed using linear mixed effect models. There were 5,298 referrals and 3,236 (61%) account activations within the year. Most users were female (72.9%) and aged between 18 and 44 years (75.4%). The CBT programs were associated with significant reductions in both depression (β = 3.34, 95% CI [3.03, 3.65], p < 0.001) and anxiety (β = 3.64, 95% CI [3.36, 3.93], p < 0.001), with large effect sizes (Cohen's d > 0.8). Time spent using the programs was also found to be a predictor of the variability in these clinical outcomes (p < 0.001), and accounting for this resulted in significantly better model fits (p < 0.001). User satisfaction ratings were also very high, exceeding 94%. Efforts to improve the representation of male and older adult users are warranted. However, overall, the results demonstrate how digital CBT can be provided at scale and lead to symptom reductions with large effect sizes for patients seeking help for depression and anxiety. The findings substantiate the continued use and expansion of this service in Ireland and the more widespread implementation of similar services in other international public healthcare settings.
Sections du résumé
BACKGROUND
BACKGROUND
In recent years, exponential growth in digital innovations and internet access has provided opportunities to deliver health services at a much greater scale than previously possible. Evidence-based technology-enabled interventions can provide cost-effective, accessible, and resource-efficient solutions for addressing mental health issues. This study evaluated the first year of a supported digital cognitive behavioral therapy (CBT) service provided by the national health service in Ireland, which has been accessible to individuals who receive a referral from one of five referring groups: General Practitioners, Primary Care Psychology, Counselling Primary Care, Community Mental Health, and Jigsaw (a nationwide youth mental health service).
METHODS
METHODS
A retrospective, observational study examining data from the service between April 2021 to April 2022 was conducted. Descriptive statistics on referrals, account activations, user demographics, program usage, and user satisfaction were extracted, and pre-to-post clinical outcomes for depression measured by the Patient Health Questionnaire-9 and for anxiety measured by the Generalised Anxiety Disorder-7 were analysed using linear mixed effect models.
RESULTS
RESULTS
There were 5,298 referrals and 3,236 (61%) account activations within the year. Most users were female (72.9%) and aged between 18 and 44 years (75.4%). The CBT programs were associated with significant reductions in both depression (β = 3.34, 95% CI [3.03, 3.65], p < 0.001) and anxiety (β = 3.64, 95% CI [3.36, 3.93], p < 0.001), with large effect sizes (Cohen's d > 0.8). Time spent using the programs was also found to be a predictor of the variability in these clinical outcomes (p < 0.001), and accounting for this resulted in significantly better model fits (p < 0.001). User satisfaction ratings were also very high, exceeding 94%.
CONCLUSIONS
CONCLUSIONS
Efforts to improve the representation of male and older adult users are warranted. However, overall, the results demonstrate how digital CBT can be provided at scale and lead to symptom reductions with large effect sizes for patients seeking help for depression and anxiety. The findings substantiate the continued use and expansion of this service in Ireland and the more widespread implementation of similar services in other international public healthcare settings.
Identifiants
pubmed: 37817270
doi: 10.1186/s13033-023-00592-9
pii: 10.1186/s13033-023-00592-9
pmc: PMC10563351
doi:
Types de publication
Journal Article
Langues
eng
Pagination
29Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Ir J Psychol Med. 2020 Mar;37(1):59-66
pubmed: 30274566
J Clin Psychiatry. 2013 Jun;74(6):595-602
pubmed: 23842011
Harv Rev Psychiatry. 2020 May/Jun;28(3):203-214
pubmed: 32310834
Ir J Med Sci. 2022 Aug;191(4):1785-1793
pubmed: 34495480
Soc Psychiatry Psychiatr Epidemiol. 2014 Oct;49(10):1641-53
pubmed: 24802317
Lancet. 2021 Nov 6;398(10312):1700-1712
pubmed: 34634250
Eur J Neurol. 2012 Jan;19(1):155-62
pubmed: 22175760
NPJ Digit Med. 2020 Jun 15;3:85
pubmed: 32566763
J Clin Psychiatry. 2019 Mar 19;80(2):
pubmed: 30900849
Psychiatry Res. 2021 Jun;300:113905
pubmed: 33827013
Br J Psychiatry. 2002 May;180:461-4
pubmed: 11983645
Aust N Z J Psychiatry. 2017 Dec;51(12):1227-1239
pubmed: 27733709
NPJ Digit Med. 2019 Dec 2;2:118
pubmed: 31815193
PLoS One. 2020 Jan 15;15(1):e0227457
pubmed: 31940325
Curr Drug Saf. 2018;13(3):176-186
pubmed: 29866014
Lancet Digit Health. 2020 Nov;2(11):e562-e563
pubmed: 33328083
Internet Interv. 2016 Jun 28;5:12-22
pubmed: 30135802
J Consult Clin Psychol. 1991 Feb;59(1):12-9
pubmed: 2002127
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Prim Care Companion CNS Disord. 2018 Mar 01;20(2):
pubmed: 29570963
J Anxiety Disord. 2018 Apr;55:70-78
pubmed: 29422409
Can J Psychiatry. 2022 Mar;67(3):192-206
pubmed: 33840264
J Anxiety Disord. 2017 Mar;46:25-34
pubmed: 27396841
Health Psychol. 1988;7(3):269-97
pubmed: 3289916
Can J Psychiatry. 2019 Jul;64(7):465-470
pubmed: 31096757
Psychol Med. 2013 Dec;43(12):2635-48
pubmed: 23419552
Lancet Psychiatry. 2022 Feb;9(2):137-150
pubmed: 35026139
J Affect Disord. 2015 Nov 1;186:171-7
pubmed: 26241666
Radiat Med. 2003 Mar-Apr;21(2):68-73
pubmed: 12816353
Br J Psychiatry. 2017 Feb;210(2):119-124
pubmed: 27908899
Patient Prefer Adherence. 2016 Jul 28;10:1401-7
pubmed: 27528803
Internet Interv. 2018 Jul 26;13:108-115
pubmed: 30206525
Med Care. 2004 Dec;42(12):1194-201
pubmed: 15550799
Annu Rev Clin Psychol. 2018 May 7;14:159-183
pubmed: 29350997
Int J Psychiatry Clin Pract. 2014 Jun;18(2):131-8
pubmed: 24527886
J Affect Disord. 2015 May 1;176:125-32
pubmed: 25704565
Curr Psychiatry Rep. 2015 Jan;17(1):533
pubmed: 25413639
Psychiatr Serv. 2015 Oct;66(10):1043-50
pubmed: 26130001
J Clin Med. 2019 Aug 17;8(8):
pubmed: 31426460
Br J Psychiatry. 2007 Apr;190:299-306
pubmed: 17401035
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
BMJ Open. 2018 Jun 14;8(6):e019716
pubmed: 29903785
Health Serv Res. 2023 Feb;58 Suppl 1:26-35
pubmed: 36054487
Clin Psychol Rev. 2004 Sep;24(5):583-616
pubmed: 15325746